Tag: Series B Financing
-
Purespring Therapeutics has raised £80 million in an oversubscribed Series B financing
•
LONDON: Syncona Ltd’s portfolio company Purespring Therapeutics, a pioneering gene therapy company focused on transforming the treatment of…
-
Climate tech company, GALY, raises $33 million in Series B financing
•
LONDON: Agronomics’ portfolio company GALY CO. has closed an oversubscribed US$ 33 million Series B financing led by Breakthrough…
-
Beacon Therapeutics raises $170 million in a Series B financing
•
Syncona Ltd announced that it has committed $42.5 million (£33.5 million) to a $170 million (£134 million) Series…
-
Syncona co-leads Series B financing in Quell Therapeutics of up to $156 million
•
LONDON, UK: Syncona Ltd has committed $25 million (£19 million) to Quell Therapeutics, a world leader in developing…
-
CinCor Pharma raises $143 million in Series B Financing
•
LONDON, UK: RTW Venture Fund Limited notes the announcement by CinCor Pharma Inc. on 12 October 2021 of…
Stay Informed with the Latest News and Updates
- Contact Us
- London Stock Exchange
- Singapore Exchange
- Canadian Exchange
- Australian Exchange
- Oslo Bourse
- PSX
- Ratings
- Euronext
- MENA
- Nasdaq Nordic
- Wire
- Business & Finance
- Gadget Reviews
- About Us: A Comprehensive Financial News Database
All news and articles on NewsnReleases are based on press releases, corporate announcements and analysts’ reports issued to London Stock Exchange (LSE), Euronext, Singapore Exchange (SGX), Japan Stock Exchange (JPX), Dubai Financial Market (DFM), Saudi Stock Exchange (Tadawul), Qatar Stock Exchange (QSE), BSEIndia, Australia Stock Exchange etc.